drugset / Trial / NCT06585540

A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population

NCT06585540

RandomizedCrossoverSingle-blindPrevention

Summary

To assess the effectiveness of Amisulpride to treat Post Operative Nausea and Vomiting (PONV) and to assess the effectiveness of Amisulpride to prevent PONV following bariatric surgery.

Timeline

Start
2024-09-13
Primary completion
2025-09
Completion
2026-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule 5 mg Intravenous
Subject Amisulpride Small molecule 10 mg Intravenous

Indications

No indication recorded.